Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin and Metronidazole for Demodex Blepharitis
NCT02236403Phase 3Completed
- Sponsor
- Universidad Nacional de Colombia
- Start
- Oct 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivermectin, metronidazole in Demodex blepharitis (DB), sponsored by Universidad Nacional de Colombia. Started Oct 2014; status: completed.
02
Drugs
ivermectinmetronidazole
03
Conditions
Demodex blepharitis (DB)
Beyond the preview
Go deeper on NCT02236403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02236403.